Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial (BMC Cardiovascular Disorders)

15 march 2019 22:04:35

Cardiovascular (CV) disease (CVD) is a well-recognized complication of type 2 diabetes mellitus (T2DM) and there is a clinical need for glucose-lowering therapies that do not further increase CV risk in this p...

80 viewsCategory: Cardiology, Pathology

Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study (BMC Cardiovascular Disorders)
Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis (BMC Cardiovascular Disorders)

blog comments powered by Disqus

MyJournals.org
The latest issues of all your favorite science journals on one page

Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial (BMC Cardiovascular Disorders)

15 march 2019 22:04:35

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice. Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten